Welcome to Markets Desk, here's what's moving.
GitLab's chief financial officer trimmed her position by just over thirty-two thousand shares, collecting roughly one point six million dollars as the stock touched a fifty-two week high in September of two thousand twenty six. Insider sales at peak valuations are worth watching — they don't signal panic, but they do signal someone at the top is taking chips off the table.
Shifting to private equity, Blackstone is exploring a sale of ZO Skin Health that could value the clinical skincare brand at around two billion dollars. The play here is instructive — Blackstone built a position in a physician-channel brand deliberately kept off mass retail shelves, betting that exclusivity and medical credibility could command premiums rivaling celebrity-backed names like Rhode or Kylie Cosmetics. The market is about to find out if that thesis holds.
Meanwhile in tech hardware, Dell, HP, and Phillips sixty-six are all trading meaningfully above their consensus analyst price targets, buoyed by artificial intelligence server demand, next-generation PC cycles, and refining margin tailwinds respectively. When a stock outruns its target, the question isn't whether analysts are wrong — it's whether the market is pricing in a future the fundamentals haven't caught up to yet.
That's the tape. Markets Desk, signing off the floor.
